<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for CYCCP</title>
    <link />
    <description>Headlines for Cyclacel Pharmaceuticals, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Cyclacel Pharmaceuticals Announces Proposed Public Offering of Common Stock</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3593572/cyclacel-pharmaceuticals-announces-proposed-public-offering-of-common-stock.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 15 May 2013 16:01:46 GMT</pubDate>
    </item>
    <item>
      <title>Cyclacel Pharmaceuticals, Inc. (CYCCP) Ex-Dividend Date Scheduled for April 17, 2013</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/cyclacel-pharmaceuticals-inc-cyccp-exdividend-date-scheduled-for-april-17-2013-cm237164.aspx?source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Tue, 16 Apr 2013 09:00:04 GMT</pubDate>
    </item>
    <item>
      <title>Cyclacel Announces Sale of Four Cyclacel Romidepsin-Related Patents to Celgene, Dismissal of All Cla</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3470714/cyclacel-announces-sale-of-four-cyclacel-romidepsin-related-patents-to-celgene-di.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 04 Apr 2013 07:13:53 GMT</pubDate>
    </item>
    <item>
      <title>Cyclacel Announces Sale of Four Cyclacel Romidepsin-Related Patents to Celgene for $5.5M</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3470713/cyclacel-announces-sale-of-four-cyclacel-romidepsin-related-patents-to-celgene-fo.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 04 Apr 2013 07:13:49 GMT</pubDate>
    </item>
    <item>
      <title>Cyclacel Pharmaceuticals, Inc. (CYCCP) Ex-Dividend Date Scheduled for January 17, 2013</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/cyclacel-pharmaceuticals-inc-cyccp-exdividend-date-scheduled-for-january-17-2013-cm207568.aspx?source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Tue, 15 Jan 2013 09:00:04 GMT</pubDate>
    </item>
    <item>
      <title>Cyclacel Comments on Key Business Objectives for 2013</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/01/3218648/cyclacel-comments-on-key-business-objectives-for-2013.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Mon, 07 Jan 2013 07:22:26 GMT</pubDate>
    </item>
    <item>
      <title>Aspire Capital Fund to Purchase Up to $20M of Cyclacel Common Stock for $6.29/Share</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/12/12/3177810/aspire-capital-fund-to-purchase-up-to-20m-of-cyclacel-common-stock-for-6-29share.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Mon, 17 Dec 2012 07:29:22 GMT</pubDate>
    </item>
  </channel>
</rss>
